Trial Profile
A phase II study evaluating the utility of letrozole in the treatment of recurrent, estrogen receptor (ER) positive, epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer,
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2006
Price :
$35
*
At a glance
- Drugs Letrozole (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 02 Feb 2006 New trial record.